Our Strategic and Commercial evaluation of pipeline programs is based on a combination of a cross-functional work stream rolled out in parallel with program specific therapeutic and market
These tailor-made analyses combined with available in-house data address:
- International disease landscapes focusing on the therapeutic behavior and clinical guidelines
- Strategic market analysis with key insights on treatment algorithms and market trends
- Competitive landscapes and the potential for new entries in the market
- Disease-specific Standard of Care and potential shifts in the near future (5 year scope)
Guidance on the implementation of the SOP and the development phase (1-2-3) dependent deliverables of the commercialization process is based on:
- Aligning the SOP and the milestone-driven required deliverables in order to clarify the roles and team's responsibilities on strategy, execution and providing feedback
- A Knowledge Center with standardized data-generating tools and activities building the foundation for creating the "Successful Label" scenarios
- A list of cross-functional key questions driving the decision making process on where to focus on, how and by when
- A methodical look to deliver an aligned Target Product Profile and a meaningful differentiated value proposition
A systematic strategic analysis of a disease landscape provides the foundation for defining the commercial opportunity.
- Defining the therapeutic behavior
- Capturing the market situation and trends
- Mapping the program specific "Centers of Excellence"
- Assessing the competitive environment and the future Standard of Care (SOC)
- Foundation for communication with stakeholders
- Data sharing for a cross-functional work stream and brand teams
- Reference for strategic value assessment for in-licensing activities
This interactive work stream with a multi-disciplinary product team enables cross-functional alignment in evaluating the value of the program.
- The innovative new product planning concept enables to make informed strategic choices by clarifying the potential Viability and Commercial Value at critical development milestones dates
- The interactive work stream stimulates the cross-functional alignment and creates a shared reality on the program
- A list of cross-functional key questions drives the decision making process on where to focus, how and by when
- The Viability Assessment leads towards the best Target Product Profile, Value Proposition, and Pricing and ultimately increasing the NPV
Development of cross-functional recommendations for improving the differentiation strategy and increasing the value proposition.
- Life Cycle Strategic Planning is based on analysis of competitive development plans and data
- The analysis leads towards a differentiation strategy with focus on the Target Label, improving the Standard of Care (SOC) and the Value Proposition and potential reimbursement
- The needs for competitive differentiation and speed to market are the strategic drivers of the Life Cycle Plan